Projects per year
Search results
-
Active
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
Wagner, J. E., Bachanova, V., Betts, B., Brunstein, C. G., Cichocki, F. M., De For, T. E., Eaton, A., Hippen, K. L., Luo, X., Maakaron, J., McKenna, D. H. & Tolar, J.
NIH NATIONAL CANCER INSTITUTE (NCI)
5/5/23 → 4/30/28
Project: Research project
-
Phase 1 Study of PBCAR19B in Subjects with CD19-expressing Malignancies
12/2/21 → 12/2/26
Project: Research project
-
Study of FT538 in Combination with Daratumumab inAcute Myeloid Leukemia
1/1/21 → 12/31/26
Project: Research project
-
A PHASE 1,0PEN-LABEL,DOSEESCALATING STUDYEVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS ANDCLINICAL ACTIVITY OF THE COMBINATION OF CLBROOI, AN ENGINEEREDAUTOLOGOUS T-CELLPRODUCT,ANDSWI019,AN ANTIBODY-BASEDBIOLOGIC, IN PATIENT
SCRIPPS RESEARCH INSTITUTE DBA CALIBR
8/19/20 → 8/30/25
Project: Research project
-
PHASE III STUDY OF DARATUMUMAB/rHuPH20 (NSC- 810307) + LENALIDOMIDE OR LENALIDOMIDE ASPOST-AUTOLOGOUS STEM CELL TRANSPLANT MAINTENANCE THERAPY IN PATIENTS WITH MULTIPLEMYELOMA (MM) USING MINIMAL RESIDUAL DISEASE TO DIRECT THERAPY DURATION (DRAMMATICST
Maakaron, J. & Janakiram, M.
THE HOPE FOUNDATION, NIH NATIONAL CANCER INSTITUTE (NCI)
8/1/20 → 7/31/25
Project: Research project
-
A Phase 1b/2 Trial of Hu5F9-G4 in Combination with Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Maakaron, J. & Pongas, G.
12/1/18 → 5/31/24
Project: Research project
-
Finished
HM2018-32 A Phase 1b Open-Label Study to Evaluate the Safety and Antitumor Activity of LoncastuximabTesirine and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
Maakaron, J., Janakiram, M. & Pongas, G.
11/1/18 → 4/30/23
Project: Research project
-
HM2017-33 : Nivolumab and Oral Cyclophosphamide for Rela
Maakaron, J., He, F. & Weisdorf, D. J.
11/1/17 → 4/30/23
Project: Research project